Peptide-Based Crop Protection Market (2026-2036)

The global peptide-based crop protection market was valued at USD 102.0 million in 2025. The market is projected to reach USD 945.0 million by 2036, growing from USD 121.0 million in 2026 at a CAGR of 22.8% during the forecast period (2026–2036).

Published
Aug 2026
Pages
295
Format
PDF + Excel
Report ID
MR-2160
Base year
2025
Market size · USD million · 2025–2036Forecast 2026–2036 · 22.8% CAGR
2025 · BASELINE
$102.0M
2036
$945.0M
CAGR 2026–2036
22.8%
$1.5B$1.13B$750M$375M0
2025
2026
'27
'28
'29
'30
'31
'32
'33
'34
'35
'36

2025 baseline · 2026–2036 forecast at 22.8% CAGR · hover a bar for the value

Key highlights

01

Bioinsecticides are expected to account for the largest share of the market in 2026, reflecting their status as the only peptide-based crop protection product category currently commercially launched and EPA-registered in the United States.

02

Biofungicides are projected to register the highest growth during the forecast period, driven by an active late-stage regulatory pipeline across the United States, European Union, Brazil, and Paraguay.

03

By peptide source, naturally derived peptides, including venom-derived and plant-derived sequences, are expected to hold the largest share in 2026, while AI-designed and computationally screened synthetic peptides are projected to register the highest growth.

04

By application method, foliar spray is expected to dominate the market in 2026, consistent with the application format of currently commercialized products.

05

By crop type, fruits and vegetables are expected to account for the largest share in 2026, while row crops, including soybean, are projected to register the highest growth as new biofungicide products complete regulatory filings targeting large-acreage field crops.

06

North America is expected to dominate this market in 2026, supported by the presence of the U.S. Environmental Protection Agency's dedicated Biopesticides and Pollution Prevention Division and the country's advanced biologicals commercialization infrastructure.

07

Europe and Latin America are expected to register above-average growth, driven by active regulatory filings for peptide biofungicides in the European Union, Brazil, and Paraguay.

Report summary

ParticularsDetails
Market Size by 2036USD 945.0 Million
Market Size in 2026USD 121.0 Million
Market Size in 2025USD 102 Million
Revenue Growth Rate (2026–2036)22.8%
FormatPDF, Excel & Cloud Portal · 295 pages
Dominating Product TypeBioinsecticides
Fastest Growing Product TypeBiofungicides
Dominating Peptide SourceNaturally Derived Peptides
Fastest Growing Peptide SourceSynthetic/AI-Designed Peptides
Dominating Application MethodFoliar Spray
Dominating Crop TypeFruits and Vegetables
Fastest Growing Crop TypeRow Crops (incl. Soybean)
Dominating GeographyNorth America
Fastest Growing GeographyEurope and Latin America
Base Year2025
Forecast Period2026 to 2036

Report overview

Market size trajectory
2025
USD 102.0 million
2026
USD 121.0 million
2036
USD 945.0 million
~7.8× expansion 2026–2036 at 22.8% CAGR
Scope note

Segments covered: product type, peptide source, application.

The global peptide-based crop protection market comprises crop protection products that use biologically active peptides or proteins to control pests and pathogens. These actives can be derived from natural sources, including plant, microbial, and venom-derived compounds, or developed through computational discovery and biotechnology platforms. Peptide-based solutions can offer highly specific biological activity and novel modes of action, creating potential advantages for resistance management and reduced impact on beneficial organisms.

Commercial activity remains concentrated among specialized biotechnology companies and major crop protection manufacturers. In May 2026, Suterra, a division of The Wonderful Company, acquired Vestaron’s product lines, active ingredients, and R&D pipeline, including the SPEAR and BASIN peptide bioinsecticide portfolios. Biotalys received U.S. EPA approval for its protein-based biofungicide EVOCA in December 2025 and obtained its first U.S. state registration in Florida in April 2026. Micropep Technologies filed regulatory dossiers for its peptide biofungicide Promisin in Brazil and Paraguay in June 2026, followed by U.S. and EU submissions in July 2026.

Market growth is supported by increasing pest and pathogen resistance to conventional chemistries and advances in AI-enabled peptide discovery. Micropep’s Krisalix platform combines peptide-design algorithms with biological screening, while its collaboration with Corteva supports development of peptide-based biocontrol solutions. Biotalys also achieved a first research milestone in its bioinsecticide collaboration with Syngenta in April 2026. AgroSpheres is developing delivery technologies for active ingredients including peptides, while FMC is a strategic investor and collaborator.

Despite strong innovation momentum, high production costs, regulatory requirements, and challenges related to peptide stability under field conditions remain important constraints. Commercialization is therefore likely to rely heavily on partnerships, licensing, and acquisitions that combine specialized peptide discovery capabilities with the regulatory, manufacturing, and distribution infrastructure of established crop protection companies.

Market dynamics

2 factors across 1 force
01

Strategic Partnerships and Acquisitions Becoming the Primary Commercialization Pathway for Peptide-Focused Biotechnology Companies

Rather than building independent global regulatory and distribution infrastructure, peptide-focused biotechnology companies are increasingly commercializing through partnership with, or acquisition by, established crop protection and biological pest control manufacturers. The clearest example is Suterra's May 2026 acquisition of Vestaron's Spear and Basin peptide bioinsecticide product lines, active ingredients, and R&D pipeline, including Vestaron's Kalamazoo, Michigan research facility; Suterra, a division of The Wonderful Company, plans to begin manufacturing its own branded version of Spear Lep later in 2026, leveraging its existing biological pest control distribution network rather than Vestaron building one independently. A parallel dynamic is visible in Biotalys's partnership with Syngenta Crop Protection AG to co-develop a novel protein-based bioinsecticide, and in Bayer AG's multi-year collaboration with AgroSpheres, alongside FMC Corporation's direct capital investment in AgroSpheres' most recent funding round. This pattern indicates that near-term market growth is likely to be realized substantially through the biologicals divisions of BASF SE, Bayer AG, Corteva Agriscience, FMC Corporation, and Syngenta Crop Protection AG, operating alongside the specialized companies that originate the underlying peptide technology.

02

Formulation Innovation Addressing Field Stability Limitations to Expand Peptide Products Beyond Their Original Target Pest Range

Peptide active ingredients are inherently more susceptible to degradation from UV exposure, heat, and digestive proteolysis than small-molecule synthetic chemistries, which has historically limited both field persistence and the range of pests a given peptide can effectively control. Recent peer-reviewed research demonstrates that fusing an insecticidal spider venom peptide to a stabilizing carrier protein, snowdrop lectin, meaningfully improves oral toxicity of the peptide toward aphid pests compared with the unmodified peptide, extending the practical target range of an already-commercialized peptide active ingredient. Separately, published research on proteolytic stabilization techniques has demonstrated that a stabilized spider venom peptide variant can achieve oral bioinsecticidal activity, addressing one of the central formulation barriers that has constrained peptide bioinsecticide development to date. These formulation advances are expected to progressively widen the addressable pest and crop range of existing peptide platforms without requiring discovery of an entirely new peptide sequence for each new target.

Table of contents

12 chapters · 110 sections · 295 pages · click to expand
Review the full research scope before you buy. Chapters can also be purchased individually.

1.1Market Definition and Scope
1.2Market Ecosystem
1.3Currency and Limitations
1.3.1Currency
1.3.2Limitations
1.4Key Stakeholders

Segmental analysis

SegmentLargest share (2026)Fastest growth (2026–2036)
By Product TypeBioinsecticidesBiofungicides
By Peptide SourceNaturally Derived PeptidesSynthetic and AI-designed peptides
By Application MethodFoliar Spray—
By Crop TypeFruits and VegetablesRow crops
01

By Product Type

  • The Bioinsecticides Segment to Dominate the Global Peptide-Based Crop Protection Market
  • The bioinsecticides segment is expected to account for the largest share of this market, reflecting the fact that spider venom-derived peptide bioinsecticides, commercialized under the Spear and Basin brands and now held by Suterra, remain the only peptide-based crop protection products with established commercial sales history and multi-year EPA registration in the United States.
  • Basin, targeting aphids, mites, drosophila, and whiteflies, received EPA approval in March 2024, expanding the pest range addressable by this product category beyond the lepidopteran pests originally targeted by Spear-Lep.
  • However, the biofungicides segment is projected to register the highest growth during the forecast period.
  • This growth is driven by an active late-stage regulatory pipeline: Micropep Technologies has filed for regulatory approval of its lead peptide biofungicide, Promisin, targeting fungal diseases including Asian soybean rust, target spot, and leaf blight, across Brazil, Paraguay, the United States, and the European Union, with commercial launch anticipated from 2027.
  • Biotalys NV's protein-based biofungicide EVOCA received U.S. EPA approval in December 2025 and Florida state registration in April 2026, with its next-generation successor, EVOCA NG, targeting Botrytis and powdery mildew in fruit and vegetable crops across a combined addressable market the company estimates at approximately USD 1.2 billion, with planned launches in the United States, Europe, and Brazil later in the forecast period.
02

By Peptide Source

  • The naturally derived peptides segment is expected to account for the largest share of this market, led by the commercially established spider venom-derived peptides in Suterra's Spear and Basin product lines and supported by an established base of peer-reviewed research characterizing naturally occurring insecticidal peptide families, including legume albumin proteins and knottin-family venom peptides.
  • However, the synthetic and AI-designed peptides segment is projected to register the highest growth during the forecast period.
  • This growth is driven by the maturation of computational discovery platforms such as Micropep's Krisalix, which designs short protein molecules to precisely regulate plant gene expression rather than relying on naturally occurring sequences, and by the broader application of protein structure prediction tools to agricultural peptide design following their earlier validation in pharmaceutical peptide drug discovery.
03

By Application Method

  • The Foliar Spray Segment to Hold the Largest Share
  • The foliar spray segment is expected to account for the largest share of this market, consistent with the labeled application format of the currently commercialized Spear, Basin, and EVOCA products, which are applied as contact or systemic foliar sprays for above-ground pest and disease control.
04

By Crop Type

  • The fruits and vegetables segment is expected to account for the largest share of this market, reflecting the specialty crop focus of currently registered products, including Spear-Lep's original 2018 approval for fruits, vegetables, and specialty field crops, and EVOCA NG's targeted launch against Botrytis and powdery mildew in fruit and vegetable crops.
  • However, the row crops segment, including soybean, is projected to register the highest growth during the forecast period, driven by Micropep's Promisin regulatory filings in Brazil and Paraguay targeting Asian soybean rust and related soy diseases, positioning peptide biofungicides for the first time toward large-acreage field crop production rather than solely specialty crop applications.

Geographic analysis

01

North America

Largest share

In 2026, North America is expected to account for the largest share of this market. This is supported by the presence of the U.S. EPA's dedicated Biopesticides and Pollution Prevention Division, which provides a defined regulatory pathway for biochemical and microbial pesticides distinct from conventional chemistries, and by the concentration of commercial and R&D activity in the region, including Suterra's Oregon headquarters, the former Vestaron Kalamazoo, Michigan research facility now held by Suterra, and AgroSpheres' Charlottesville, Virginia platform.

02

Europe

Europe represents an important and growing market, anchored by Biotalys NV's Ghent, Belgium headquarters and Micropep Technologies' Toulouse, France research origins, alongside active EU regulatory filings for both companies' lead biofungicide products. Regulatory conditions in the region have shifted since 2024, however, following the European Commission's withdrawal of the proposed Regulation on the Sustainable Use of Plant Protection Products, which would have introduced binding EU-wide pesticide reduction targets; pesticide governance in the EU now continues under the existing Sustainable Use Directive and national action plans, without new binding reduction mandates.

03

Latin America

Latin America, particularly Brazil and Paraguay, is emerging as an important early market for peptide biofungicides targeting soybean disease, reflecting Micropep's initial regulatory filing sequence in the region ahead of its U.S. and EU submissions, and the scale of the region's soybean production base.

04

Asia-Pacific

Asia Pacific and the Middle East and Africa remain in earlier stages of peptide-based crop protection adoption, with initial commercial activity emerging through partnerships such as Elemental Enzymes' 2026 biofungicide launch with Adama in the Australian wheat market.

Competitive landscape

Companies profiled (3)
  • Micropep Technologies
  • Biotalys NV
  • AgroSpheres

Frequently asked questions

The global peptide-based crop protection market was valued at USD 102 million in 2025. The market is projected to reach USD 945.0 million by 2036, growing from USD 121.0 million in 2026 at a CAGR of 22.8% during the forecast period (2026–2036).

Cite this report

Meticulous Research. (2026). Peptide-Based Crop Protection Market - Global Opportunity Analysis and Industry Forecast (2026-2036) (Report No. MR-2160). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/peptide-based-crop-protection-market-6843

Search Market Intelligence

Search across reports, blogs, press releases, and industries